1. Home
  2. CULP vs RFL Comparison

CULP vs RFL Comparison

Compare CULP & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Culp Inc.

CULP

Culp Inc.

HOLD

Current Price

$3.18

Market Cap

43.8M

ML Signal

HOLD

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$1.49

Market Cap

61.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CULP
RFL
Founded
1972
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Textiles
Real Estate
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
43.8M
61.1M
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
CULP
RFL
Price
$3.18
$1.49
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
21.1K
58.8K
Earning Date
03-09-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.28
EPS
N/A
N/A
Revenue
$213,237,000.00
$917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.83
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.96
52 Week Low
$3.17
$1.12
52 Week High
$5.64
$3.19

Technical Indicators

Market Signals
Indicator
CULP
RFL
Relative Strength Index (RSI) 30.92 76.62
Support Level N/A $1.41
Resistance Level $4.05 $1.60
Average True Range (ATR) 0.15 0.07
MACD -0.03 0.02
Stochastic Oscillator 11.54 75.61

Price Performance

Historical Comparison
CULP
RFL

About CULP Culp Inc.

Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: